Cart
sales@molnova.com
2-MNG
CAS No. 2101538-28-5
2-MNG( —— )
Catalog No. M37607 CAS No. 2101538-28-5
2-MNG (2-Mercaptonicotinoyl glycine) acts as an inhibitor of melanin production, displaying an average IC50 of 49.5μM in normal human melanocytes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2-MNG
-
NoteResearch use only, not for human use.
-
Brief Description2-MNG (2-Mercaptonicotinoyl glycine) acts as an inhibitor of melanin production, displaying an average IC50 of 49.5μM in normal human melanocytes.
-
Description2-MNG (2-Mercaptonicotinoyl glycine) acts as an inhibitor of melanin production, displaying an average IC50 of 49.5μM in normal human melanocytes. It binds to melanin precursors, preventing their incorporation into growing melanin which results in the inhibition of eumelanin and pheomelanin synthesis. Additionally, 2-MNG can be used in studies related to skin pigmentation disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2101538-28-5
-
Formula Weight212.23
-
Molecular FormulaC8H8N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)CNC(=O)C1=CC=CNC1=S
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Lysionotin
Lysionotin has expectorant, eliminating phlegm, softening effects.
-
Difopein TFA (396834...
Difopein (TFA), a specific and competitive inhibitor of 14-3-3 protein (a highly conserved eukaryotic regulatory molecule), blocking the ability of 14-3-3 to bind to target proteins and inhibits 14-3-3/Ligand interactions. Difopein (TFA) leads to induction of apoptosis and enhances the ability of cisplatin to kill cells.
-
Isopropyl laurate
Isopropyl laurate can be used in coatings, inks, detergents, and other fields.
